Atypical Chronic Myeloid Leukemia — Trials

Atypical Chronic Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

39 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01159067	Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload	terminated	Phase 2	1	City of Hope Medical CenterOTHER	1	Jun 18, 2019	clinicaltrials
NCT00509249	Aflibercept in Treating Patients With Myelodysplastic Syndromes	terminated	Phase 2	18	National Cancer Institute (NCI)NIH	1	Jan 8, 2015	clinicaltrials